Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Aug 15, 2019; 11(8): 589-598
Published online Aug 15, 2019. doi: 10.4251/wjgo.v11.i8.589
Published online Aug 15, 2019. doi: 10.4251/wjgo.v11.i8.589
Percentage | |
Gender | |
Female | 46.8 |
Male | 52.4 |
Age of initial diagnosis | |
Average | 66.9 ± 13 |
Minimum | 31 |
maximum | 90 |
Tumor stage | |
Stage I | 16.2 |
Stage IA | 0.2 |
Stage II | 6.5 |
Stage IIA | 29.9 |
Stage IIB | 2.2 |
Stage IIC | 0.2 |
Stage III | 4.3 |
Stage IIIA | 1.7 |
Stage IIIB | 12.8 |
Stage IIIC | 8.9 |
Stage IV | 10.0 |
Stage IVA | 3.7 |
Stage IVB | 0.4 |
Not reported | 2.4 |
Discrepant | 0.6 |
- Citation: Nfonsam LE, Jandova J, Jecius HC, Omesiete PN, Nfonsam VN. SFRP4 expression correlates with epithelial mesenchymal transition-linked genes and poor overall survival in colon cancer patients. World J Gastrointest Oncol 2019; 11(8): 589-598
- URL: https://www.wjgnet.com/1948-5204/full/v11/i8/589.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i8.589